Clin2
NCT07335510Possibly a fitRecruiting

Baroreflex therapy for heart failure patients

HFrEF - Heart Failure With Reduced Ejection Fraction

Part of Heart & circulation clinical trials.

This trial tests a device that stimulates a nerve in your neck to help your heart pump better. It is for people with heart failure and a weak heart pump who still have symptoms despite taking medications.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
58 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have heart failure with a weak pump (ejection fraction of 35% or less) – measured within the last year
  • You currently have shortness of breath or fatigue with minimal activity (NYHA Class III) or you have symptoms with moderate activity (Class II) and had worse symptoms in the past (Class III)
  • A blood test in the last 3 months shows a specific heart stress marker (NT-proBNP) is below 1600 pg/ml
  • You are on the best tolerated heart failure medications and have any needed heart devices in place
  • You are 18 years or older

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT02880618Recruiting
Barostim therapy for heart failure with reduced pumping ability

This trial tests a device called Barostim NEO that is implanted in the neck to help treat heart failure. It may improve symptoms by stimulating nerves that help the heart work better.

Hamburg, Free and Hanseatic City of Hamburg
NCT07399587Recruiting· Phase 2/Phase 3
Optimizing heart failure treatment with two devices

This study tests whether using two implanted devices (CardioMems and BaroStim) can improve heart function and symptoms in people with advanced heart failure. It aims to help patients who are already on standard medications get even better results.

Riverhead, New York
NCT07232030Recruiting
Barostim device for heart failure treatment

This trial tests a device called Barostim, which is implanted under the skin to stimulate nerves that help control heart failure. It's for people with mild to moderate heart failure whose symptoms are not fully controlled by medications.

Mobile, Alabama
NCT06052072Enrolling by invitation
Heart failure trial testing nerve treatment for lung pressure

This trial tests a new treatment that uses a device to calm overactive nerves in the lung's blood vessels. It is for heart failure patients who also have high blood pressure in their lungs, to see if it can help them breathe easier and feel better.

Chicago, Illinois
NCT06552637Recruiting
Diaphragm stimulation for heart failure

This trial tests a device that stimulates your diaphragm (the muscle that helps you breathe) while you have heart failure. It may help improve your breathing and heart function. The study is for people with moderate heart failure symptoms whose heart pumps less blood than normal.

Indianapolis, Indiana
NCT06355388Not yet recruiting
Ear nerve stimulation for chronic heart failure

This trial tests a non-invasive device that sends gentle electrical pulses to a nerve in your ear (vagus nerve) to see if it improves heart function in people with chronic heart failure. If you have heart failure with a reduced pumping ability, you may be able to join.

Pisa, Pi

Hear when a new HFrEF - Heart Failure With Reduced Ejection Fraction trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.